Cited by 357Antimicrobial Resistance in StaphylococcusAntibiotic Use and ResistancePharmacovigilance and Adverse Drug Reactions

Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study

Open access
Blumenthal, Kimberly G, Lu, Na, Zhang, Yuqing, Li, Yu, Walensky, Rochelle P, Choi, Hyon K·2018·BMJ

Abstract

Abstract Objective To evaluate the relation between penicillin allergy and development of meticillin resistant Staphylococcus aureus (MRSA) and C difficile. Design Population based matched cohort study. Setting United Kingdom general practice (1995-2015). Participants 301 399 adults without previous MRSA or C difficile enrolled in the Health Improvement Network database: 64 141 had a penicillin allergy and 237 258 comparators matched on age, sex, and study entry time. Main outcome measures The primary outcome was risk of incident MRSA and C difficile. Secondary outcomes were use of β lactam antibiotics and β lactam alternative antibiotics. Results Among 64 141 adults with penicillin allergy and 237 258 matched comparators, 1365 developed MRSA (442 participants with penicillin allergy and 923 comparators) and 1688 developed C difficile (442 participants with penicillin allergy and 1246 comparators) during a mean 6.0 years of follow-up. Among patients with penicillin allergy the adjusted hazard ratio for MRSA was 1.69 (95% confidence interval 1.51 to 1.90) and for C difficile was 1.26 (1.12 to 1.40). The adjusted incidence rate ratios for antibiotic use among patients with penicillin allergy were 4.15 (95% confidence interval 4.12 to 4.17) for macrolides, 3.89 (3.66 to 4.12) for clindamycin, and 2.10 (2.08 to 2.13) for fluoroquinolones. Increased use of β lactam alternative antibiotics accounted for 55% of the increased risk of MRSA and 35% of the increased risk of C difficile. Conclusions Documented penicillin allergy was associated with an increased risk of MRSA and C difficile that was mediated by the increased use of β lactam alternative antibiotics. Systematically addressing penicillin allergies may be an important public health strategy to reduce the incidence of MRSA and C difficile among patients with a penicillin allergy label.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.k2400

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Multiple studies have described that persons with reported penicillin or another ß-lactam antibiotic allergy have higher rates of surgical-site infections, methicillin-resistant Staphylococcus aureus infections, and higher medical care usage.

    “Multiple studies have described that persons with reported penicillin or another ß-lactam antibiotic allergy have higher rates of surgical-site infections, methicillin-resistant Staphylococcus aureus infections, and higher medical care usage (653,662–664).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [663]

    The Results and Discussion report a higher risk of MRSA among patients with a documented penicillin allergy. The paper does not report higher surgical-site infection rates, and its healthcare-visit and hospital-admission figures are baseline characteristics rather than a finding of higher medical care usage. The study also does not establish these outcomes for other β-lactam allergy labels. Page numbers are unavailable in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Blumenthal, K. G., Lu, N., Zhang, Y., Li, Y., Walensky, R. P., & Choi, H. K.
Affiliations
  • Harvard University (US)
  • Massachusetts General Hospital (US)
Corresponding author
Blumenthal, Kimberly G
Venue
BMJ
Publisher
BMJ
Published
2018-06-27
Volume
361
Pages
k2400
ISSN
  • 1756-1833 (ISSN-L)
  • 0959-8138
OpenAlex
W2810697168
Cited by
357
References
46
Citations by year
2026: 38 · 2025: 49 · 2024: 49 · 2023: 42 · 2022: 41 · 2021: 43 · 2020: 41 · 2019: 44 · 2018: 10
FWCI
26.10
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion, cc-by-nc)
Funders
  • American Academy of Allergy Asthma and Immunology (K01AI125631)
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (K01AI125631)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords
penicillin allergy, methicillin-resistant Staphylococcus aureus, Clostridium difficile, Clostridium difficile infection, macrolides, clindamycin, fluoroquinolones, antibiotic use, general practice, antibiotic stewardship
MeSH terms
Adult, Aged, Clostridium Infections, Drug Hypersensitivity, Female, United Kingdom, Humans, Male, Middle Aged, Penicillins, Staphylococcal Infections, Cohort Studies, Incidence, Clostridioides difficile, Methicillin-Resistant Staphylococcus aureus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review